drugset / Trial / NCT02340104
A Study to Measure Baricitinib (LY3009104) Absorption in Healthy Participants
NaSingle-groupOpen-labelBasic science
Summary
The purpose of this study is to compare how much baricitinib (study drug) gets into the blood stream when it is given as a single dose (in tablet form) and as an intravenous infusion (injection given directly into a vein via a small needle). Each participant in the study will make four visits to the investigator site over the course of about 6 weeks.
Timeline
- Start
- 2015-01
- Primary completion
- 2015-02
- Completion
- 2015-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Baricitinib | Small molecule | 4 mg | Oral |
| Subject | [^13C4D3^15N]-baricitinib | Unknown | 4 ug | Intravenous |
Indications
No indication recorded.